All stock lists
Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
Healthcare · Biotechnology
1.06+0.08 (+7.61%)
Website
Insider Score
––Not scored
ESLA Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ESLA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 684.01 K | 891.79 K | 587.78 K | 648.51 K | 883.73 K | — |
| R&D Expense | 1.40 M | 1.40 M | 25.41 K | 4.15 M | 4.66 M | — |
| Operating Expenses | 2.08 M | 2.29 M | 613.20 K | 4.80 M | 5.54 M | — |
| Operating Income | -2.08 M | -2.29 M | -613.20 K | -4.80 M | -5.54 M | — |
| Pretax Income | -2.31 M | -2.29 M | -613.20 K | -4.80 M | -5.54 M | — |
| Tax Provision | 0.00 | 0.00 | -25.00 | 0.00 | 850.00 | — |
| Net Income | -2.31 M | -2.29 M | -613.17 K | -4.80 M | -5.54 M | — |
| EPS (Basic) | -0.05 | -0.05 | — | -0.13 | -0.15 | -0.06 |
| EPS (Diluted) | -0.05 | -0.05 | — | -0.13 | -0.15 | -0.06 |
| Shares Outstanding | 43.00 M | 42.12 M | — | 37.10 M | 36.17 M | 36.19 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.